"Pneumococcal Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Infections with bacteria of the species STREPTOCOCCUS PNEUMONIAE.
| Descriptor ID |
D011008
|
| MeSH Number(s) |
C01.252.410.890.670
|
| Concept/Terms |
Pneumococcal Infections- Pneumococcal Infections
- Infections, Pneumococcal
- Infection, Pneumococcal
- Pneumococcal Infection
- Streptococcus pneumoniae Infections
- Infections, Streptococcus pneumoniae
- Infection, Streptococcus pneumoniae
- Streptococcus pneumoniae Infection
- Pneumococcal Diseases
- Disease, Pneumococcal
- Diseases, Pneumococcal
- Pneumococcal Disease
|
Below are MeSH descriptors whose meaning is more general than "Pneumococcal Infections".
Below are MeSH descriptors whose meaning is more specific than "Pneumococcal Infections".
This graph shows the total number of publications written about "Pneumococcal Infections" by people in this website by year, and whether "Pneumococcal Infections" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 2 | 0 | 2 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 1 | 2 |
| 2002 | 1 | 2 | 3 |
| 2003 | 3 | 0 | 3 |
| 2004 | 2 | 0 | 2 |
| 2005 | 4 | 0 | 4 |
| 2006 | 3 | 1 | 4 |
| 2007 | 5 | 1 | 6 |
| 2008 | 4 | 0 | 4 |
| 2009 | 5 | 0 | 5 |
| 2011 | 7 | 1 | 8 |
| 2012 | 7 | 4 | 11 |
| 2013 | 7 | 0 | 7 |
| 2014 | 7 | 4 | 11 |
| 2015 | 8 | 1 | 9 |
| 2016 | 6 | 1 | 7 |
| 2017 | 11 | 2 | 13 |
| 2018 | 4 | 0 | 4 |
| 2019 | 7 | 1 | 8 |
| 2020 | 9 | 1 | 10 |
| 2021 | 7 | 1 | 8 |
| 2022 | 4 | 0 | 4 |
| 2023 | 8 | 0 | 8 |
| 2024 | 5 | 1 | 6 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pneumococcal Infections" by people in Profiles.
-
Serotype-specific serum immunoglobulin G at 18 months of age following one or two doses of a primary series of 10-valent or 13-valent pneumococcal conjugate vaccine and a booster dose at nine months of age: a randomized controlled study. Expert Rev Vaccines. 2025 Dec; 24(1):121-127.
-
Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysis. Lancet Infect Dis. 2025 Apr; 25(4):457-470.
-
Single priming and a booster dose of 10-valent and 13-valent pneumococcal conjugate vaccine (PCV) maintains suppression of vaccine serotype colonization in South African children at 3, 4, and 5 years of age: a single-centre, open-labelled, randomized trial. Expert Rev Vaccines. 2024 Jan-Dec; 23(1):1011-1019.
-
Impact of pneumococcal conjugate vaccines on invasive pneumococcal disease-causing lineages among South African children. Nat Commun. 2024 Sep 27; 15(1):8401.
-
Long-term effect of pneumococcal conjugate vaccines on invasive pneumococcal disease incidence among people of all ages from national, active, laboratory-based surveillance in South Africa, 2005-19: a cohort observational study. Lancet Glob Health. 2024 Sep; 12(9):e1470-e1484.
-
Geographical migration and fitness dynamics of Streptococcus pneumoniae. Nature. 2024 Jul; 631(8020):386-392.
-
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis. Health Technol Assess. 2024 Jul; 28(34):1-109.
-
The Global Burden of Community-Acquired Pneumonia in Adults, Encompassing Invasive Pneumococcal Disease and the Prevalence of Its Associated Cardiovascular Events, with a Focus on Pneumolysin and Macrolide Antibiotics in Pathogenesis and Therapy. Int J Mol Sci. 2023 Jul 03; 24(13).
-
Streptococcus pneumoniae and other bacterial nasopharyngeal colonization seven years post-introduction of 13-valent pneumococcal conjugate vaccine in South African children. Int J Infect Dis. 2023 Sep; 134:45-52.
-
All-cause and pathogen-specific lower respiratory tract infection hospital admissions in children younger than 5 years during the COVID-19 pandemic (2020-22) compared with the pre-pandemic period (2015-19) in South Africa: an observational study. Lancet Infect Dis. 2023 09; 23(9):1031-1041.